Osaic Holdings’s Tenaya Therapeutics TNYA Stock Holding History

Osaic Holdings’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6K	Sell	34,563 -4,900	-12%	-$3.72K	﹤0.01%	5975
2026 Q1	$27.2K	Buy	39,463 +5,063	+15%	+$3.74K	﹤0.01%	5652
2025 Q4	$24.4K	Buy	34,400 +400	+1%	+$544	﹤0.01%	5740
2025 Q3	$53.7K	Hold	34,000	–	–	﹤0.01%	5264
2025 Q2	$20.7K	Sell	34,000 -664	-2%	-$338	﹤0.01%	5679
2025 Q1	$19.8K	Buy	34,664 +664	+2%	+$655	﹤0.01%	5374
2024 Q4	$48.6K	Buy	+34,000	New	+$76.2K	﹤0.01%	4722
2024 Q3	–	Sell	-38	Closed	-$118	–	7555
2024 Q2	$118	Buy	+38	New	+$157	﹤0.01%	7231
2023 Q3	–	Sell	-250	Closed	-$1.47K	–	7538
2023 Q2	$1.47K	Buy	250 +161	+181%	+$936	﹤0.01%	6762
2023 Q1	$254	Hold	89	–	–	﹤0.01%	7236
2022 Q4	$0	Buy	+89	New	+$217	﹤0.01%	7426
2022 Q1	–	Sell	-26	Closed	–	–	7500
2021 Q4	$0	Buy	+26	New	+$567	﹤0.01%	7569

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's TNYA Position: Q2 2026 in Review

Osaic Holdings reduced its Tenaya Therapeutics (TNYA) stake by 12% in Q2 2026, selling an estimated $3.72K and leaving 34,563 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5975.

Osaic Holdings first reported a position in TNYA in Q4 2021 and has held it in 12 quarters since. The position peaked at $53.7K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Osaic Holdings held 34,563 shares of Tenaya Therapeutics worth $25.6K as of Q2 2026.
Osaic Holdings sold 4,900 Tenaya Therapeutics shares in Q2 2026, an estimated $3.72K.
Tenaya Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5975 holding.
Osaic Holdings first reported a position in Tenaya Therapeutics in Q4 2021 and has held it in 12 quarters since.
Osaic Holdings's Tenaya Therapeutics position peaked at $53.7K in Q3 2025.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.